Tumour budding is a novel marker in breast cancer: the clinical application and future prospects-Reference-Cited by-同舟云学术

Tumour budding is a novel marker in breast cancer: the clinical application and future prospects

Published:2022-05-10 Issue:1 Volume:54 Page:1303-1312
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Huang Ting¹,Bao Hui²,Meng Yu-hua³,Zhu Jian-lin⁴,Chu Xiao-dong⁴,Chu Xiao-li⁵⁶,Pan Jing-hua⁴

Affiliation:

1. Department of Clinical Pathology, the First Affiliated Hospital of Jinan University, Guangzhou, China

2. Department of Plastic Surgery, the First Affiliated Hospital of Jinan University, Guangzhou, China

3. Department of Clinical Pathology, the First People's Hospital of Shunde, Foshan, China

4. Department of General Surgery, the First Affiliated Hospital of Jinan University, Guangzhou, China

5. State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong, China

6. Guangdong Provincial Key laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou, China

Funder

the First Affiliated Hospital of Jinan University Flagship Specialty Construction Project-General Surgery

the Guangdong Basic and Applied Basic Research

the Fundamental Research Business Expenses of Central Universities

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2022.2070272

Reference59 articles.

1. Cancer statistics, 2022

2. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016

3. Tumor Budding: The Name is EMT. Partial EMT.

4. Depth of invasion, tumor budding, and worst pattern of invasion: Prognostic indicators in early‐stage oral tongue cancer

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor Budding: A Novel Prognostic Marker in Breast Carcinoma with Correlation of Histopathological and Immunohistochemical Parameters;South Asian Journal of Cancer;2024-08-28

2. GAS5 lncRNA: A biomarker and therapeutic target in breast cancer;Pathology - Research and Practice;2024-08

3. Tumour budding, MELF-pattern and tumour-infiltrating lymphocytes as possible pathomorphological parameters of the course of endometrioid adenocarcinoma of the uterine corpus;Tumors of female reproductive system;2024-07-29

4. Identification of Tumor Budding-Associated Genes in Breast Cancer through Transcriptomic Profiling and Network Diffusion Analysis;Biomolecules;2024-07-24

5. Triple‐negative breast cancer survival prediction using artificial intelligence through integrated analysis of tertiary lymphoid structures and tumor budding;Cancer;2024-02-29